Article
AJMC Sets Infectious Disease Meeting for Atlanta
The American Journal of Managed Care will host a two-day event September 25-26, 2014, to take on some of healthcare's biggest challenges: Treatments that cure hepatitis C are making news but upending balance sheets. A recent recommendation seeks preventive therapy to stop new cases of HIV. Hospitals and public health officials are grappling with how to prevent the spread of MERS. Only AJMC will bring payers, clinicians, policy leaders, and pharmaceutical representatives together to share ideas.
PLAINSBORO, N.J. — The realm of infectious disease offers some of the nation’s greatest recent healthcare successes and its biggest challenges. Discussions about curing hepatitis C, preventing HIV, stopping hospital-acquired infections, and overusing antibiotics demand input from all parts of the system.
To do that, The American Journal of Managed Care will bring together stakeholders for a two-day live meeting, “Value-Based Decision-Making in Infectious Disease,” to be held September 25-26, 2014, at the Loews Atlanta Hotel. For information and registration, click here.
“New therapies, and new ways to use them, present today’s toughest decisions for payers and employers. Everyone who has a stake in these conversations should come share ideas, hear from leaders in the field, and leave with new resources for information,” said Brian Haug, president of The American Journal of Managed Care.
The format features speakers, panel discussions, networking, and participation from attendees. Agenda topics will include:
- Preventing infections in both hospital and community healthcare settings
- Improving outcomes in viral hepatitis
- Addressing today’s challenges in preventing and treating HIV.
Speakers already scheduled to participate in the event include:
- Edina Avdic, PharmD, MBA, BCPS, associate professor, Antimicrobial Stewardship Program, The Johns Hopkins Hospital, Baltimore, Md.
- Christine S. Brennan, PhD, RN, NP-BC, assistant professor, Health Policy and System Management, Louisiana State University Health Sciences Center, New Orleans, La.
- David C. Epstein, MD, MBA, medical director, Aetna, Atlanta.
- Michael Mugavero, MD, MHSc, associate professor, University of Alabama School of Medicine, Birmingham, Ala.
- Andrew J. Muir, MD, MHS, associate professor of medicine and clinical director, Hepatology, Duke Gastroenterology, Durham, N.C.
- Igho Ofotokun, MD, MSc, associate professor, Emory School of Medicine, Atlanta.
- John H. Powers, MD, FACP, FIDSA, assistant clinical professor, George Washington School of Medicine, Washington, D.C.
- William Schaffner, MD, professor and chair, Department of Preventive Medicine, Division of Infectious Diseases, Vanderbilt University School of Medicine, Nashville, Tenn.
Serving as moderators will be Jan Berger, MD, MJ, President and CEO of Health Intelligence Partners, Chicago, who is also editor-in-chief of The American Journal of Pharmacy Benefits, and Robert Navarro, PharmD, clinical professor, Pharmaceutical Outcomes and Policy, University of Florida College of Pharmacy, Gainesville, Fla.
About the Journal
The American Journal of Managed Care, now in its 20th year of publication, is the leading peer-reviewed journal dedicated to issues in managed care. In December 2013, AJMC launched The American Journal of Accountable Care, which publishes research and commentary devoted to understanding changes to the healthcare system due to the 2010 Affordable Care Act. AJMC’s news publications, the Evidence-Based series, bring together stakeholder views from payers, providers, policymakers and pharmaceutical leaders in the areas of oncology, diabetes management, respiratory care, and immunology and infectious disease.
CONTACT: Mary Caffrey (609) 716-7777 x 144
